Subacute Cerebral Infarction

KEY FACTS

TERMINOLOGY

• Subacute infarction ~ 2-14 days following initial ischemic

event

IMAGING

• Best diagnostic clue: Gyral edema and enhancement within

basal ganglia and cortex

• Typically wedge-shaped abnormality involving gray and

white matter within vascular distribution

• Hemorrhagic transformation of initially ischemic infarction

occurs in 20-25% of middle cerebral artery occlusions,

usually by 48-72 h

• "2-2-2" rule = enhancement begins at 2 days, peaks at 2

weeks, disappears by 2 months

• MRS: ↑ lactate, ↓ NAA within infarcted tissue

• DWI:  ↑ diffusion restriction, ↓ ADC initially, reversing as it

proceeds into/through subacute stage

• "Fogging" effect = normal T2WI with striking enhancement

on T1WI C+ 1-2 weeks following ictus

TOP DIFFERENTIAL DIAGNOSES

• Neoplasm

• Venous infarction

• Encephalitis/cerebritis

CLINICAL ISSUES

• Acute-onset focal neurologic deficit

• Elderly patient with typical risk factors: Hypertension,

diabetes, smoking history, obesity, hypercholesterolemia

• 1st month after infarction, mortality predominantly from

neurologic complications; 1:4 die of recurrent stroke event

• Acute anticoagulation after 1st infarction reduces mortality

DIAGNOSTIC CHECKLIST

• Enhancement is key to defining subacute stage of cerebral

infarction

• Subacute ischemia often mimics neoplasm

○ Recommend short-term follow-up to ensure expected

course of evolution

(Left) Axial CT obtained 48 h

after initial onset of weakness

and speech difficulties shows

the classic appearance of an

early subacute cerebral

infarct. Note the wedgeshaped, low-density area ſt

involving both the gray and

white matter in the left middle

cerebral artery distribution.

(Right) Axial FLAIR MR in a 58-

year-old man 1 week after

onset of visual changes shows

classic imaging of a subacute

infarct with hyperintensity in

the cortex and subcortical WM

of the occipital lobe ﬇ in a

posterior cerebral artery (PCA)

distribution.

(Left) Axial DWI in the same

patient shows hyperintensity

within the left PCA

distribution. The

hyperintensity represents a

combination of true diffusion

restriction and T2 shine

through. (Right) Axial T1 C+

MR in the same patient shows

gyriform enhancement along

the cortex of the occipital lobe

﬇. This enhancement may be

seen as early as 2 days and

may last up to 2 months after

the patient's initial ischemic

event. Without clinical history,

imaging may mimic a tumor,

venous infarct, or cerebritis.

Brain: Pathology-Based Diagnoses: Malformations,

Trauma, and Stroke

98

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more